PET-guided treatment for personalised therapy of Hodgkin lymphoma and aggressive non-Hodgkin lymphoma-Reference-Cited by-同舟云学术

PET-guided treatment for personalised therapy of Hodgkin lymphoma and aggressive non-Hodgkin lymphoma

Published:2021-11-01 Issue:1127 Volume:94 Page:
ISSN:0007-1285
Container-title:The British Journal of Radiology
language:en
Short-container-title:BJR

Author:

Phillips Elizabeth H¹²^ORCID,Iype Rohan³,Wirth Andrew⁴

Affiliation:

1. Division of Cancer Sciences, University of Manchester, Manchester, UK

2. Department of Medical Oncology, The Christie Hospital NHS Foundation Trust, Manchester, UK

3. Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia

4. Department of Clinical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia

Abstract

FDG-PET scanning has a central role in lymphoma staging and response assessment. There is a growing body of evidence that PET response assessment during and after initial systemic therapy can provide useful prognostic information, and PET response has an evolving role in guiding patient care. This review provides a perspective on the role of PET response assessment for individualised management of patients with the most common aggressive lymphomas, Hodgkin lymphoma and diffuse large B-cell lymphoma.

Publisher

British Institute of Radiology

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Link

https://www.birpublications.org/doi/pdf/10.1259/bjr.20210576

Reference91 articles.

1. Use of Positron Emission Tomography for Response Assessment of Lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma

2. Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group

3. Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma

4. Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification

5. Results of a Trial of PET-Directed Therapy for Early-Stage Hodgkin’s Lymphoma

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Modern Low Dose Involved Site Radiation Therapy on Normal Tissue Toxicity in Cervicothoracic Non-Hodgkin Lymphomas: A Biophysical Study;Cancers;2023-12-05

2. The Potential Effect of PET on Radiotherapy Treatment Planning in Neuro-oncology;Nuclear Medicine Seminars;2023-11-01

3. [18F]FDG-PET-Based Personalized Radiotherapy Dose Prescription;Seminars in Radiation Oncology;2023-07

4. Prognostic value of the completeness of the metabolic response in patients with diffused large B-cell lymphoma;Proceedings of the National Academy of Sciences of Belarus, Medical series;2023-03-01

5. Staging and response assessment of lymphoma: a brief review of the Lugano classification and the role of FDG-PET/CT;Blood Research;2022-04-30